Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Highest Revenue (PRX, CPD, HITK, AKRX)

Below are the top small-cap drugs-generic stocks on the NYSE, the NASDAQ and the AMEX in terms of revenue. The trailing-twelve-month revenue at Pharmaceutical Companies PRX is $1.01 billion. PRX's ROE for the same period is 16.46%. The trailing-twelve-month revenue at Caraco Pharmaceutical Laboratories Ltd CPD is $323.44 million. CPD had $63.69 million in total cash for the recent quarter. The trailing-twelve-month revenue at Hi-Tech Pharmacal Co Inc HITK is $175.84 million. HITK's PEG ratio is 0.69. The trailing-twelve-month revenue at Akorn Inc AKRX is $86.41 million. AKRX's ROE for the same period is 34.81%. Trading Ideas.